Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder

Introduction The pharmacological management of women with bipolar disorder in the perinatal period is challenging. This population has a high recurrence rate, but some medications can be a concern in pregnancy and breastfeeding. Little is known about prescribing practices in perinatal services, an...

Full description

Bibliographic Details
Main Authors: M. Casanova Dias, I. Jones, A. Wieck
Format: Article
Language:English
Published: Cambridge University Press 2021-04-01
Series:European Psychiatry
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S0924933821002406/type/journal_article
_version_ 1827754059193384960
author M. Casanova Dias
I. Jones
A. Wieck
author_facet M. Casanova Dias
I. Jones
A. Wieck
author_sort M. Casanova Dias
collection DOAJ
description Introduction The pharmacological management of women with bipolar disorder in the perinatal period is challenging. This population has a high recurrence rate, but some medications can be a concern in pregnancy and breastfeeding. Little is known about prescribing practices in perinatal services, and the impact of medication on recurrence rates. Objectives To describe 1. the use of medication in women with bipolar disorder in the perinatal period and 2. the impact of medication on the rate of recurrence. Methods Clinical data was collected from pregnant women with diagnosis of bipolar disorder in the nine participating centres and who were not experiencing an episode of illness entering the postpartum period. Data were analysed for association using χ2 tests and logistic regression. Results In this sample of 167 women, 55% were taking medication at delivery: 37% antipsychotics, 15% mood stabilisers, 25% antidepressants. In 12 cases medication was reduced before delivery. 42% experienced a recurrence, with 30% being a manic/psychotic episode. There was no significant association between taking medication and recurrence c2(1)=0.72, p=0.79. There continued to be no association when adjusted for severity (previous admissions, age at first treatment, bipolar subtype) and type of medication OR 0.57 95%CI [0.08; 4.29], p=0.59. Conclusions A high number of bipolar women are taking medication before delivery and in the majority antipsychotics are prescribed. The postnatal recurrence rate in both medicated and unmedicated women is high. Further work is needed in larger samples to provide clinical guidance for women and their clinicians. Disclosure No significant relationships.
first_indexed 2024-03-11T07:44:07Z
format Article
id doaj.art-4908fd8932764750871bb44dd29ca5ce
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:44:07Z
publishDate 2021-04-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-4908fd8932764750871bb44dd29ca5ce2023-11-17T05:07:53ZengCambridge University PressEuropean Psychiatry0924-93381778-35852021-04-0164S80S8010.1192/j.eurpsy.2021.240Multicentre evaluation of perinatal pharmacological management in women with bipolar disorderM. Casanova Dias0I. Jones1A. Wieck2National Centre For Mental Health, School Of Medicine, Cardiff University, Cardiff, United KingdomNational Centre For Mental Health, School Of Medicine, Cardiff University, Cardiff, United KingdomGreater Manchester Mental Health Foundation Trust, University of Manchester, Manchester, United Kingdom Introduction The pharmacological management of women with bipolar disorder in the perinatal period is challenging. This population has a high recurrence rate, but some medications can be a concern in pregnancy and breastfeeding. Little is known about prescribing practices in perinatal services, and the impact of medication on recurrence rates. Objectives To describe 1. the use of medication in women with bipolar disorder in the perinatal period and 2. the impact of medication on the rate of recurrence. Methods Clinical data was collected from pregnant women with diagnosis of bipolar disorder in the nine participating centres and who were not experiencing an episode of illness entering the postpartum period. Data were analysed for association using χ2 tests and logistic regression. Results In this sample of 167 women, 55% were taking medication at delivery: 37% antipsychotics, 15% mood stabilisers, 25% antidepressants. In 12 cases medication was reduced before delivery. 42% experienced a recurrence, with 30% being a manic/psychotic episode. There was no significant association between taking medication and recurrence c2(1)=0.72, p=0.79. There continued to be no association when adjusted for severity (previous admissions, age at first treatment, bipolar subtype) and type of medication OR 0.57 95%CI [0.08; 4.29], p=0.59. Conclusions A high number of bipolar women are taking medication before delivery and in the majority antipsychotics are prescribed. The postnatal recurrence rate in both medicated and unmedicated women is high. Further work is needed in larger samples to provide clinical guidance for women and their clinicians. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S0924933821002406/type/journal_articlebipolar disorderpregnancyPostpartumperinatal
spellingShingle M. Casanova Dias
I. Jones
A. Wieck
Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
European Psychiatry
bipolar disorder
pregnancy
Postpartum
perinatal
title Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
title_full Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
title_fullStr Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
title_full_unstemmed Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
title_short Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
title_sort multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
topic bipolar disorder
pregnancy
Postpartum
perinatal
url https://www.cambridge.org/core/product/identifier/S0924933821002406/type/journal_article
work_keys_str_mv AT mcasanovadias multicentreevaluationofperinatalpharmacologicalmanagementinwomenwithbipolardisorder
AT ijones multicentreevaluationofperinatalpharmacologicalmanagementinwomenwithbipolardisorder
AT awieck multicentreevaluationofperinatalpharmacologicalmanagementinwomenwithbipolardisorder